Amgen SEC filings, summarized
We read every Amgen 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track AMGN in your inbox
Add Amgen to your watchlist — free, every morning.
Recent filings
AMGEN filed an underwriting agreement dated Feb 17, 2026 — BofA Securities, Citigroup, J.P.
AMGEN filed an underwriting agreement dated Feb 17, 2026 — BofA Securities, Citigroup, J.P. Morgan & Morgan Stanley named as lead reps for a registered…
BREAKING: $AMGN sold $4.0B of senior notes across 2031/2036/2046/2056 maturities — net proceeds ≈ $3.961B.
BREAKING: $AMGN sold $4.0B of senior notes across 2031/2036/2046/2056 maturities — net proceeds ≈ $3.961B. 🚨💰 #AMGN #Bonds #Debt #Markets ALERT: Locks in…
AMGEN filed an 8-K (Item 9.01) on Feb 3, 2026 attaching a press release as Exhibit 99.1 (dated Feb 3, 2026).
AMGEN filed an 8-K (Item 9.01) on Feb 3, 2026 attaching a press release as Exhibit 99.1 (dated Feb 3, 2026). 📄 $AMGN #SECfiling #Amgen The filing also…
Amgen filed a Termination Agreement with Kyowa Kirin dated Jan 30, 2026 (Exhibit 10.1).
Amgen filed a Termination Agreement with Kyowa Kirin dated Jan 30, 2026 (Exhibit 10.1). Portions of the exhibit are redacted as confidential; 8‑K discloses…
On Jan 30, 2026 Amgen ($AMGN) entered a Termination Agreement with Kyowa Kirin to end the June 1, 2021…
On Jan 30, 2026 Amgen ($AMGN) entered a Termination Agreement with Kyowa Kirin to end the June 1, 2021 License & Collaboration Agreement; termination will…